Bortezomib Proteasome inhibitor

The University of Nebraska Medical Center, a state agency under the Board of Regents of the University of Nebraska, awarded a Purchase Order (PO) to Selleck Chemicals LLC, a vendor based in Houston, Texas, on February 26, 2026. The contract, identified as PO 4800182617, covers the procurement of one unit of Bortezomib Proteasome inhibitor (material number S1013-5mg) for a total contract value of $147.00. The scheduled delivery date is March 4, 2026, with performance occurring at the University of Nebraska Medical Center's Shipping and Receiving facility in Omaha, Nebraska, and final destination at DRC I 6058 under the direction of Mohsin Raza.

Payment terms are established as Net 30 with freight prepaid on an Free On Board Destination basis. The purchase order is governed by the Standard Terms of Purchase as outlined on the University of Nebraska's procurement website, and the vendor is required to acknowledge acceptance within 10 days of the order date. The tax-exempt entity number for the University of Nebraska Medical Center is 05-8905401, and all invoices and related documentation must clearly display the purchase order number. The contracting department buyer may be reached at 402-472-2126 for administrative inquiries.